If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXeros Tech Regulatory News (XSG)

Share Price Information for Xeros Tech (XSG)

Share Price is delayed by 15 minutes
Get Live Data
1.70    0.00 (0.00%)
Bid:
1.65
Ask:
1.75
Spread: 0.10 (6.061%)
Market Cap: £14.65m
XSG Live PriceLast checked at - London Stock Exchange

Intraday Xeros Tech Share Chart

Domestic XFilter Independent Test Validation

14 Jun 2022 07:01

RNS Number : 7135O
Xeros Technology Group plc
14 June 2022
 

 

14 June 2022

 

Xeros Technology Group plc

 

('Xeros' or the 'Company' or the 'Group')

 

DOMESTIC XFILTER INDEPENDENT TEST VALIDATION

 

Xeros Technology Group plc (AIM: XSG), the creator of technologies that reduce the impact of clothing on the planet, is today providing an update on results from independent testing of their domestic washing machine filtration technology, XFilter.

Hohenstein, based in Bonnigheim Germany, a highly respected testing institute for the textile industry, has accredited Xeros' filtration device, XFilter, with the highest level of performance, capturing over 99% of microplastics. These tests were carried out on behalf of a leading Asian domestic washing machine OEM as part of the test and trial agreement signed with Xeros in July 2021.

The test analysed the retention rate of microplastics using an XFilter device integrated into a washing machine provided by our OEM partner. These independently conducted tests consistently showed performance levels of over 99% capture rate, thereby confirming XFilter as the leading commercially available microplastic filtration device. A detailed summary of the test results will be made available on our website.

These test results, combined with the recently announced licencing agreement with Hanning, a leading component supplier to the global washing machine industry, provide further evidence of the potential demand for XFilter. Xeros expects to move to commercial licensing discussions with our Asian OEM partner in the coming months and will provide further updates when appropriate.

 

Klaas de Boer, Chairman of Xeros, said:

 

"These test results provide further validation of the market leading performance of our XFilter technology, and we thank Hohenstein for their work in performing the tests. We are confident that this will accelerate our progress with the multiple parties with whom we are currently engaged."

 

 

Enquiries:

Xeros Technology Group plc

Klaas de Boer, Chairman

Mark Nichols, Chief Executive Officer

Paul Denney, Chief Financial Officer

Tel: 0114 321 6328

 

finnCap Limited (Nominated Adviser and Broker)

Julian Blunt/Teddy Whiley, Corporate Finance

Andrew Burdis/Sunila de Silva, ECM

 

Yellow Jersey PR

Sarah Hollins/Lilian Filips/Laurie Gellhorn

Tel: 020 7220 0570

 

 

 

Tel: 020 3004 9512

 

 

Notes to Editors

 

POWERED BY SCIENCE, XEROS CREATE TECHNOLOGIES ENGINEERED FOR THE FUTURE

 

Born out of textile research and advancing new standards of performance and responsibility, Xeros' technologies revolutionise the way we make and clean our clothes, conserving water and preventing waste. Designed to impact industries and people on a global scale, Xeros transform the performance, impact and economics of the fashion and washing machine industry. 

 

Xeros enable the scaling of their innovations and impact by licencing their intellectual property to partners across the globe. Their work has, to date, created 38 patent families.

 

Xeros' technologies are already in use in major global industries, including commercial and home laundry and garment manufacture. So far, these technologies have saved millions of litres of water and could prevent billions of microfibres from ending in our oceans.

TO THE POWER OF CHANGE  

xerostech.com

 

 

About Hohenstein

 

Hohenstien is a highly accredited internationally recognised institute. With over 75 years of experience in the testing, certification, and research of all kinds of textile products they are neutral and conform to a number of assessment bodies. 

 

hohenstein.com

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBKNBNABKDCAD
Date   Source Headline
1st Jul 20268:00 amRNSBlock Listing Six Monthly Return
10th Jun 20263:11 pmRNSResult of AGM
28th Apr 20267:00 amRNSFull Year Results 2025
21st Apr 20267:00 amRNSNotice of Results and Online Presentation
5th Mar 20267:00 amRNSPurchase Order ahead of European Launch of XF3
11th Feb 202610:39 amRNSHolding(s) in Company
2nd Feb 20267:00 amRNSBoard Change
27th Jan 20267:00 amRNSTrading Update
7th Jan 20262:52 pmRNSTR-1 First Equity
2nd Jan 202611:46 amRNSBlock listing Interim Review
11th Dec 20251:06 pmRNSTR-1 Entrepreneurs Fund
2nd Dec 20254:48 pmRNSTR-1 Lombard Odier
2nd Dec 20252:26 pmRNSTR-1 Dowgate
2nd Dec 202511:10 amRNSTR-1 Maven
28th Nov 202511:02 amRNSResults of General Meeting and Director Dealings
27th Nov 202512:28 pmRNSResult of Follow-on Subscription and TVR
26th Nov 20254:44 pmRNSTR-1 Spreadex
11th Nov 20251:14 pmRNSResult of Retail Offer
7th Nov 202510:15 amRNSResult of Fundraising
7th Nov 20257:00 amRNSRetail Offer
6th Nov 20256:32 pmRNSProposed Fundraise
24th Oct 20253:07 pmRNSBlock listing Interim Review
14th Oct 20255:11 pmRNSTR-1 Maven
10th Oct 20255:20 pmRNSTR-1 Dowgate
9th Oct 20252:05 pmRNSTR-1 Spreadex
9th Oct 202511:04 amRNSTR-1 First Equity
8th Oct 20257:00 amRNSBreakthrough Launch Agreement
1st Oct 20252:08 pmRNS-RInterim Results 2025 Online Presentation
30th Sep 20257:00 amRNSInterim Results 2025
15th Sep 20256:07 pmRNSTR-1 Dowgate
12th Sep 20251:03 pmRNSTR-1 Dowgate
5th Aug 202512:13 pmRNSTR-1 First Equity
7th Jul 20252:33 pmRNSTR-1 Spreadex
19th Jun 20251:46 pmRNSResult of AGM
5th Jun 202510:11 amRNSCorrection - Application for Block Listing
4th Jun 202510:00 amRNSApplication for Block Listing
29th May 20252:43 pmRNSTR-1 Spreadex
28th May 20253:32 pmRNSTR-1 First Equity
28th May 20252:31 pmRNSTR-1 Spreadex
27th May 20252:37 pmRNSNotice of AGM and Posting of Annual Report
20th May 20257:00 amRNSFull Year Results 2024 and Trading Update
9th May 202511:08 amRNSTR-1 Spreadex
7th May 20257:00 amRNSNotice of Results and Online Presentation
6th May 202510:10 amRNSTR-1 Maven Capital
2nd May 20254:00 pmRNSTR-1 Spreadex
1st May 20254:35 pmRNSTR-1 - First Equity
31st Mar 20257:00 amRNSGrant of Options
7th Mar 202512:56 pmRNSTR-1 Spreadex
17th Feb 20252:18 pmRNSTR-1 Spreadex
17th Feb 202511:07 amRNSTR-1 First Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.